Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |